Literature DB >> 19652631

Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005.

Lauren Christiansen-Lindquist1, Guoyu Tao, Karen Hoover, Robbie Frank, Charlotte Kent.   

Abstract

OBJECTIVE: To estimate chlamydia screening rates of young sexually active Medicaid-insured women by race and ethnicity and age from 2002 to 2005.
METHODS: Using Medicaid child claims data from the MarketScan database, we estimated the proportion of sexually active women aged 15 to 21 years screened for chlamydia by race and ethnicity and by age group (15-16, 17-18, and 19-21 years) using codes for medical diagnostic and procedural claims.
RESULTS: Overall, chlamydia screening increased from 34% in 2002 to 44% in 2005. In all years, black women had significantly higher screening rates compared with white women (e.g., 51% vs. 39% in 2005). When stratified by age, black women were still significantly more likely to be screened for chlamydia than white women.
CONCLUSIONS: Although it is encouraging that screening has increased over time and that black women were more likely to be screened than white women, rates remain suboptimal for all women. Effective and targeted interventions are needed to improve chlamydia screening of young women. As interventions to increase screening are developed and implemented, the estimation method described in this article can be used to track chlamydia screening trends in racial and ethnic populations over time.

Entities:  

Mesh:

Year:  2009        PMID: 19652631     DOI: 10.1097/OLQ.0b013e3181ab481b

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Chlamydia trachomatis infection among women 26 to 39 years of age in the United States, 1999 to 2010.

Authors:  Elizabeth A Torrone; William M Geisler; Thomas L Gift; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2013-04       Impact factor: 2.830

2.  Racial/Ethnic Disparities in the Lifetime Risk of Chlamydia trachomatis Diagnosis and Adverse Reproductive Health Outcomes Among Women in King County, Washington.

Authors:  Laura C Chambers; Christine M Khosropour; David A Katz; Julia C Dombrowski; Lisa E Manhart; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

3.  Venous thromboembolism in the US: does race matter?

Authors:  Steven B Deitelzweig; Jay Lin; Barbara H Johnson; Kathy L Schulman
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

4.  Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013.

Authors:  Chirag G Patel; Harrell W Chesson; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2016-03       Impact factor: 2.830

5.  Higher yet suboptimal chlamydia testing rates at community health centers and outpatient clinics compared with physician offices.

Authors:  Jeffrey M Eugene; Karen W Hoover; Guoyu Tao; Charlotte K Kent
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

6.  Gonorrhea and Chlamydia Testing and Case Rates Among Women Veterans in the Veterans Health Administration.

Authors:  Shimrit Keddem; Marissa Maier; Carolyn Gardella; Joleen Borgerding; Elliott Lowy; Maggie Chartier; Sally Haskell; Ronald G Hauser; Lauren A Beste
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

7.  Disparities in state-mandated third-trimester testing for syphilis.

Authors:  Amelia C Clement; Kathryn E Fay; Lynn M Yee
Journal:  Am J Obstet Gynecol MFM       Date:  2022-02-15

8.  The Influence of Screening, Misclassification, and Reporting Biases on Reported Chlamydia Case Rates Among Young Women in the United States, 2000 Through 2017.

Authors:  Emily R Learner; Kimberly A Powers; Elizabeth A Torrone; Brian W Pence; Jason P Fine; William C Miller
Journal:  Sex Transm Dis       Date:  2020-06       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.